ANGIOTECH PHARMACEUTICALS INC - FORM 10-K - EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 - March 16, 2010

Attached files

file filename
10-K - FORM 10-K - ANGIOTECH PHARMACEUTICALS INCd10k.htm
EX-21 - LIST OF WORLDWIDE SUBSIDIARIES - ANGIOTECH PHARMACEUTICALS INCdex21.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex311.htm
EX-14.2 - GUIDE OF BUSINESS CONDUCT - ANGIOTECH PHARMACEUTICALS INCdex142.htm
EX-14.1 - CODE OF ETHICS FOR CEO, CFO AND SVP FINANCE - ANGIOTECH PHARMACEUTICALS INCdex141.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - ANGIOTECH PHARMACEUTICALS INCdex231.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ANGIOTECH PHARMACEUTICALS INCdex312.htm
EX-10.29 - EXECUTIVE EMPLOYMENT AGREEMENT - ANGIOTECH PHARMACEUTICALS INCdex1029.htm

EXHIBIT 32.1

Certification of CEO and CFO Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Angiotech Pharmaceuticals, Inc. (the “Company”), each hereby certifies that to his knowledge on the date hereof:

(a) The Form 10-K of the Company for the year-ended December 31, 2009, filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

   
Date: March 16, 2010     /S/    WILLIAM L. HUNTER        
   

William L. Hunter, M.D.

Chief Executive Officer

   
Date: March 16, 2010     /S/    K. THOMAS BAILEY        
   

K. Thomas Bailey

Chief Financial Officer

ANGIOTECH PHARMACEUTICALS INC Reports